COMP <GO>
SGRY vs NHC // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Surgery Partners Inc. (NASDAQ) VS. National HealthCare Corporation (NYSE) • 15-METRIC TALLY: SGRY 5
— NHC 6
■ METRIC PARITY
LAST: $23.21 (-0.13%) • MKT CAP: $3.04B
options-implied-move
—
LAST: $212.16 (+0.18%) • MKT CAP: $3.32B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SGRY VS. NHC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SGRY | NHC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | 10.10% | -0.20 | NHC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.7x | 20.5x | -10.80 | SGRY | /valuation <GO> |
| Free Cash Flow Yield | 6.44% | 4.47% | +1.97 | SGRY | /fcf-yield <GO> |
| Operating Margin | 45.80% | 8.50% | +37.30 | SGRY | /operating-margins <GO> |
| Net Profit Margin | -9.20% | 7.90% | -17.10 | NHC | /net-margins <GO> |
| Revenue Growth (YoY) | 6.60% | 16.10% | -9.50 | NHC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.16% | -1.16 | NHC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.67 | 6.61 | -5.94 | NHC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 86.2 | 35.1 | +51.10 | SGRY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.0x | 23.3x | -1.30 | SGRY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.04B | $3.32B | -$284.1M | NHC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SGRY REV | NHC REV | SGRY GROSS % | NHC GROSS % | SGRY FCF | NHC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $1.52B | — | — | $195.6M | $148.6M |
| FY 2024 | $0 | $1.31B | — | — | $209.7M | $79.7M |
| FY 2023 | $0 | $1.14B | — | — | $293.8M | $111.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SGRY // BETA 0.99
NHC // BETA —